Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing

Questions: Discounts, Updates etc.

Pages: 180

Price (Single): $3500

Price (Departmental):

Price (Company):

Publication Date: 2009-01-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.

A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the core competency of pharmaceutical and biotechnology drug makers.

Detail on Biopharmaceutical Markets

The growing number of biotechnology-driven protein and peptide drugs, antibiotics, chemotherapeutic agents and other compounds administered as sterile injectables, with its concomitant technological requirements, has brought about an increase in the demand for contract sterile manufacturing services. The sheer numbers of biologics in the pipeline are driving drug makers to outsource specialized production rather than build new plants.

As part of its unique coverage of the outsourcing markets for manufacturing and sales, this report includes

Traditionally, large pharmaceutical companies considered sales and marketing a core competency, and built in-house sales teams and the infrastructure to support promotional activities, launches and general portfolio expansion. However, in recent years, consistent with the "lean-and-mean" business model evolving in the pharmaceutical industry, sales and marketing is shifting—albeit slowly—from a core competency to a prime candidate for outsourcing.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

CHAPTER TWO: MEETING THE CHALLENGES OF A CHANGING MARKETPLACE

CHAPTER THREE: CONTRACT MANUFACTURING

CHAPTER FOUR: CONTRACT SALES AND MARKETING

CHAPTER FIVE: CONTRACT MANUFACTURING ORGANIZATIONS

CHAPTER SIX: CONTRACT SALES AND MARKETING COMPANY PROFILES

APPENDIX: COMPANY NAMES AND ADDRESSES

Figures and Tables

 

 

CHAPTER ONE: EXECUTIVE SUMMARY

CHAPTER TWO: MEETING THE CHALLENGES OF A CHANGING MARKETPLACE

CHAPTER THREE: CONTRACT MANUFACTURING

CHAPTER FOUR: CONTRACT SALES AND MARKETING

Other users found this report page using the following search terms: Biopharmaceutical biologic outsourcing contract manufacturing contract sales pharmaceutical manufacturing outsourcing pharma marketing market industry uk

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.